Microport Scientific Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Microport Scientific Corporation - overview
Established
1998
Location
Shanghai, Shanghai, China
Primary Industry
Medical Devices & Equipment
About
Founded in 1998 and based in Shanghai, China, Microport Scientific Corporation operates as a provider of medical device that provides electrophysiological medical devices. The company has acquired 12,000 patents and has branch offices in Suzhou, Jiaxing, etc. In December 2016, New Alliance Capital invested in Microport Scientific Corporation. The company is mainly engaged in the research and development, production and sales of a full range of medical devices.
Products include left atrial appendage guidance system, vascular interventional surgery robot, arthroscopic surgery system, etc. Its products can be used in orthopedics, electrophysiology, neurointervention and other fields. The company generates revenue by providing orthopedic medical devices, electrophysiological medical devices and other products.
Current Investors
Essex Woodlands, Carlyle Group, New Alliance Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Medical Equipment Distributors, Monitoring Equipment, Surgical Devices
Website
www.microport.com
Verticals
Artificial Intelligence, HealthTech, Manufacturing, Robotics
Company Stage
Mature
Total Amount Raised
Subscriber access only
Microport Scientific Corporation - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 129,972,230.976 | 147,531,944.223 | 152,416,198.337 | 355,284,000 | 375,844,000 | 389,921,000 | 444,190,000 | 669,490,000 | - | - | - |
| % Revenue Growth (YoY) | - | 13.5% | 3.3% | 133.1% | 5.8% | 3.7% | 13.9% | 50.7% | - | - | - |
| EBITDA (USD) | 63,765,162.774 | 72,752,856.947 | 41,557,957.471 | (1,731,000) | 47,627,000 | 82,012,000 | 82,429,000 | 94,430,000 | - | - | - |
| Operating Income (USD) | 58,100,140.267 | 66,088,292.857 | 34,388,234.76 | (39,366,000) | 10,024,000 | 45,931,000 | 47,861,000 | 52,054,000 | - | - | - |
| Operating Margin | 44.7% | 44.8% | 22.6% | (11.1%) | 2.7% | 11.8% | 10.8% | 7.8% | - | - | - |
| % EBITDA Margin | 49.1% | 49.3% | 27.3% | (0.5%) | 12.7% | 21.0% | 18.6% | 14.1% | - | - | - |
| NET Income (USD) | 49,654,449.99 | 56,096,121.663 | 24,117,358.547 | (59,571,000) | (11,379,000) | 15,069,000 | 16,951,000 | 18,381,000 | - | - | - |
| % Net Margin | 38.2% | 38.0% | 15.8% | (16.8%) | (3.0%) | 3.9% | 3.8% | 2.7% | - | - | - |
Microport Scientific Corporation - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Hemovent GmbH | - | ||||||||
| Private Placement/Follow on | Completed | Microport Scientific Corporation | - | ||||||||
| Add-on | Completed | LivaNova’s Cardiac Rhythm Management Business Franchise | - | ||||||||
| PIPE | Completed | Microport Scientific Corporation | - | ||||||||
| PIPE | Completed | Microport Scientific Corporation | - |
Displaying 1 - 5 of 7
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.